22nd Market Capitalization from 2010 to 2025

XXII Stock  USD 1.44  0.17  10.56%   
22nd Century's Market Cap is decreasing with stable movements from year to year. Market Cap is predicted to flatten to about 373.5 M.
Check 22nd Century financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among 22nd Century's main balance sheet or income statement drivers, such as Interest Expense of 2.2 M, Selling General Administrative of 10.1 M or Other Operating Expenses of 30.5 M, as well as many indicators such as Price To Sales Ratio of 62.17, Dividend Yield of 0.0106 or PTB Ratio of 184. 22nd financial statements analysis is a perfect complement when working with 22nd Century Valuation or Volatility modules.
  
Check out the analysis of 22nd Century Correlation against competitors.

Latest 22nd Century's Market Capitalization Growth Pattern

Below is the plot of the Market Cap of 22nd Century Group over the last few years. It is 22nd Century's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in 22nd Century's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 3.81 M10 Years Trend
Pretty Stable
   Market Cap   
       Timeline  

22nd Market Capitalization Regression Statistics

Arithmetic Mean501,451,700
Geometric Mean499,309,976
Coefficient Of Variation8.92
Mean Deviation31,131,616
Median520,609,617
Standard Deviation44,722,802
Sample Variance2000.1T
Range147.1M
R-Value(0.20)
Mean Square Error2058T
R-Squared0.04
Significance0.46
Slope(1,870,773)
Total Sum of Squares30001.9T

22nd Market Capitalization History

2025373.5 M
2024468.5 M
2011520.6 M
2010413.2 M

About 22nd Century Financial Statements

Investors use fundamental indicators, such as 22nd Century's Market Capitalization, to determine how well the company is positioned to perform in the future. Although 22nd Century's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. The company has collaboration with Keygene N.V. to develop hempcannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York. 22nd Century operates under Tobacco classification in the United States and is traded on NASDAQ Exchange. It employs 76 people.

Currently Active Assets on Macroaxis

When determining whether 22nd Century Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of 22nd Century's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of 22nd Century Group Stock. Outlined below are crucial reports that will aid in making a well-informed decision on 22nd Century Group Stock:
Check out the analysis of 22nd Century Correlation against competitors.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Tobacco space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 22nd Century. If investors know 22nd will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 22nd Century listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(157.62)
Revenue Per Share
166.553
Quarterly Revenue Growth
(0.24)
Return On Assets
(0.35)
Return On Equity
(3.86)
The market value of 22nd Century Group is measured differently than its book value, which is the value of 22nd that is recorded on the company's balance sheet. Investors also form their own opinion of 22nd Century's value that differs from its market value or its book value, called intrinsic value, which is 22nd Century's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 22nd Century's market value can be influenced by many factors that don't directly affect 22nd Century's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 22nd Century's value and its price as these two are different measures arrived at by different means. Investors typically determine if 22nd Century is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 22nd Century's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.